{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T21:47:07Z","timestamp":1788817627478,"version":"build-2803163510"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2014,12,17]],"date-time":"2014-12-17T00:00:00Z","timestamp":1418774400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurotox Res"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1007\/s12640-014-9510-z","type":"journal-article","created":{"date-parts":[[2014,12,16]],"date-time":"2014-12-16T14:10:16Z","timestamp":1418739016000},"page":"275-283","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Interaction Between the Endocannabinoid and Serotonergic System in the Exhibition of Head Twitch Response in Four Mouse Strains"],"prefix":"10.1007","volume":"27","author":[{"given":"Chiara","family":"Ceci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Proietti Onori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Macr\u00ec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Laviola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,12,17]]},"reference":[{"key":"9510_CR1","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1124\/jpet.111.180257","volume":"338","author":"K Ahn","year":"2011","unstructured":"Ahn K, Smith SE, Liimatta MB, Beidler D, Sadagopan N, Dudley DT, Young T, Wren P, Zhang Y, Swaney S, Van Becelaere K, Blankman JL, Nomura DK, Bhattachar SN, Stiff C, Nomanbhoy TK, Weerapana E, Johnson DS, Cravatt BF (2011) Mechanistic and pharmacological characterization of PF-04457845: a highly potent and selective fatty acid amide hydrolase inhibitor that reduces inflammatory and noninflammatory pain. J Pharmacol Exp Ther 338:114\u2013124","journal-title":"J Pharmacol Exp Ther"},{"key":"9510_CR2","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.neuropharm.2013.12.018","volume":"81","author":"WB Anderson","year":"2013","unstructured":"Anderson WB, Gould MJ, Torres RD, Mitchell VA, Vaughan CW (2013) Actions of the dual FAAH\/MAGL inhibitor JZL195 in a murine inflammatory pain model. Neuropharmacology 81:224\u2013230","journal-title":"Neuropharmacology"},{"key":"9510_CR3","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1081\/CBI-120014105","volume":"19","author":"L Ayalon","year":"2002","unstructured":"Ayalon L, Hermesh H, Dagan Y (2002) Case study of circadian rhythm sleep disorder following haloperidol treatment: reversal by risperidone and melatonin. Chronobiol Int 19:947\u2013959","journal-title":"Chronobiol Int"},{"key":"9510_CR4","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/S0028-3908(99)00010-6","volume":"38","author":"NM Barnes","year":"1999","unstructured":"Barnes NM, Sharp T (1999) A review of central 5-HT receptors and their function. Neuropharmacology 38:1083\u20131152","journal-title":"Neuropharmacology"},{"key":"9510_CR5","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/0028-3908(95)00166-2","volume":"35","author":"MH Baumann","year":"1996","unstructured":"Baumann MH, Rothman RB (1996) Chronic cocaine exposure potentiates prolactin and head shake responses to 5-HT2 receptor stimulation in rats. Neuropharmacology 35:295\u2013301","journal-title":"Neuropharmacology"},{"issue":"Suppl 1","key":"9510_CR6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2826.2008.01676.x","volume":"20","author":"T Bisogno","year":"2008","unstructured":"Bisogno T (2008) Endogenous cannabinoids: structure and metabolism. J Neuroendocrinol 20(Suppl 1):1\u20139","journal-title":"J Neuroendocrinol"},{"key":"9510_CR7","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1006\/bbrc.1999.0254","volume":"256","author":"T Bisogno","year":"1999","unstructured":"Bisogno T, Berrendero F, Ambrosino G, Cebeira M, Ramos JA, Fernandez-Ruiz JJ, Di Marzo V (1999) Brain regional distribution of endocannabinoids: implications for their biosynthesis and biological function. Biochem Biophys Res Commun 256:377\u2013380","journal-title":"Biochem Biophys Res Commun"},{"key":"9510_CR8","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1002\/dta.1333","volume":"4","author":"CE Canal","year":"2012","unstructured":"Canal CE, Morgan D (2012) Head-twitch response in rodents induced by the hallucinogen 2,5-dimethoxy-4-iodoamphetamine: a comprehensive history, a re-evaluation of mechanisms, and its utility as a model. Drug Test Anal 4:556\u2013576","journal-title":"Drug Test Anal"},{"key":"9510_CR9","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1136\/jnnp.2010.225029","volume":"82","author":"AE Cavanna","year":"2011","unstructured":"Cavanna AE, Critchley HD, Orth M, Stern JS, Young MB, Robertson MM (2011) Dissecting the Gilles de la Tourette spectrum: a factor analytic study on 639 patients. J Neurol Neurosurg Psychiatry 82:1320\u20131323","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"9510_CR10","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0028-3908(98)00208-1","volume":"38","author":"JF Cheer","year":"1999","unstructured":"Cheer JF, Cadogan AK, Marsden CA, Fone KC, Kendall DA (1999) Modification of 5-HT2 receptor mediated behaviour in the rat by oleamide and the role of cannabinoid receptors. Neuropharmacology 38:533\u2013541","journal-title":"Neuropharmacology"},{"key":"9510_CR11","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1365-2710.2010.01164.x","volume":"36","author":"FD Christopoulou","year":"2011","unstructured":"Christopoulou FD, Kiortsis DN (2011) An overview of the metabolic effects of rimonabant in randomized controlled trials: potential for other cannabinoid 1 receptor blockers in obesity. J Clin Pharm Ther 36:10\u201318","journal-title":"J Clin Pharm Ther"},{"key":"9510_CR12","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1126\/science.284.5420.1670","volume":"284","author":"JC Crabbe","year":"1999","unstructured":"Crabbe JC, Wahlsten D, Dudek BC (1999) Genetics of mouse behavior: interactions with laboratory environment. Science 284:1670\u20131672","journal-title":"Science"},{"key":"9510_CR13","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0091-3057(00)00477-9","volume":"68","author":"NA Darmani","year":"2001","unstructured":"Darmani NA (2001) Cannabinoids of diverse structure inhibit two DOI-induced 5-HT(2A) receptor-mediated behaviors in mice. Pharmacol Biochem Behav 68:311\u2013317","journal-title":"Pharmacol Biochem Behav"},{"key":"9510_CR14","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1007\/s007020070043","volume":"107","author":"NA Darmani","year":"2000","unstructured":"Darmani NA, Pandya DK (2000) Involvement of other neurotransmitters in behaviors induced by the cannabinoid CB1 receptor antagonist SR 141716A in naive mice. J Neural Transm 107:931\u2013945","journal-title":"J Neural Transm"},{"key":"9510_CR15","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0091-3057(90)90047-L","volume":"37","author":"NA Darmani","year":"1990","unstructured":"Darmani NA, Martin BR, Pandey U, Glennon RA (1990) Pharmacological characterization of ear-scratch response in mice as a behavioral model for selective 5-HT2-receptor agonists and evidence for 5-HT1B- and 5-HT2-receptor interactions. Pharmacol Biochem Behav 37:95\u201399","journal-title":"Pharmacol Biochem Behav"},{"key":"9510_CR16","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1126\/science.1470919","volume":"258","author":"WA Devane","year":"1992","unstructured":"Devane WA et al (1992) Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258:1946\u20131949","journal-title":"Science"},{"key":"9510_CR17","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1042\/bj3310015","volume":"331","author":"V Marzo Di","year":"1998","unstructured":"Di Marzo V, Bisogno T, Sugiura T, Melck D, De Petrocellis L (1998) The novel endogenous cannabinoid 2-arachidonoylglycerol is inactivated by neuronal- and basophil-like cells: connections with anandamide. Biochem J 331:15\u201319","journal-title":"Biochem J"},{"key":"9510_CR100","doi-asserted-by":"crossref","unstructured":"Egashira N, Mishima K, Uchida T, Hasebe N, Nagai H, Mizuki A, Iwasaki K, Ishii H, Nishimura R, Shoyama Y, Fujiwara M (2004) Anandamide inhibits the DOI-induced head-twitch response in mice. Psychopharmacology 174:382\u2013389","DOI":"10.1007\/s00213-003-1611-y"},{"key":"9510_CR18","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.pbb.2011.04.003","volume":"99","author":"N Egashira","year":"2011","unstructured":"Egashira N, Shirakawa A, Okuno R, Mishima K, Iwasaki K, Oishi R, Fujiwara M (2011) Role of endocannabinoid and glutamatergic systems in DOI-induced head-twitch response in mice. Pharmacol Biochem Behav 99:52\u201358","journal-title":"Pharmacol Biochem Behav"},{"key":"9510_CR19","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1124\/jpet.110.172247","volume":"335","author":"WE Fantegrossi","year":"2010","unstructured":"Fantegrossi WE, Simoneau J, Cohen MS, Zimmerman SM, Henson CM, Rice KC, Woods JH (2010) Interaction of 5-HT2A and 5-HT2C receptors in R(\u2013)-2,5-dimethoxy-4-iodoamphetamine-elicited head twitch behavior in mice. J Pharmacol Exp Ther 335:728\u2013734","journal-title":"J Pharmacol Exp Ther"},{"key":"9510_CR20","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1124\/jpet.104.078980","volume":"313","author":"D Fegley","year":"2005","unstructured":"Fegley D, Gaetani S, Duranti A, Tontini A, Mor M, Tarzia G, Piomelli D (2005) Characterization of the fatty acid amide hydrolase inhibitor cyclohexyl carbamic acid 3\u2032-carbamoyl-biphenyl-3-yl ester (URB597): effects on anandamide and oleoylethanolamide deactivation. J Pharmacol Exp Ther 313:352\u2013358","journal-title":"J Pharmacol Exp Ther"},{"key":"9510_CR21","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s002130000558","volume":"153","author":"CM Gaynor","year":"2001","unstructured":"Gaynor CM, Handley SL (2001) Effects of nicotine on head-shakes and tryptophan metabolites. Psychopharmacology 153:327\u2013333","journal-title":"Psychopharmacology"},{"key":"9510_CR22","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0306-4522(00)00008-7","volume":"97","author":"M Glass","year":"2000","unstructured":"Glass M, Dragunow M, Faull RL (2000) The pattern of neurodegeneration in Huntington\u2019s disease: a comparative study of cannabinoid, dopamine, adenosine and GABA(A) receptor alterations in the human basal ganglia in Huntington\u2019s disease. Neuroscience 97:505\u2013519","journal-title":"Neuroscience"},{"key":"9510_CR23","doi-asserted-by":"crossref","first-page":"18620","DOI":"10.1073\/pnas.0509591102","volume":"102","author":"G Gobbi","year":"2005","unstructured":"Gobbi G, Bambico FR, Mangieri R, Bortolato M, Campolongo P, Solinas M, Cassano T, Morgese MG, Debonnel G, Duranti A, Tontini A, Tarzia G, Mor M, Trezza V, Goldberg SR, Cuomo V, Piomelli D (2005) Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis. Proc Natl Acad Sci USA 102:18620\u201318625","journal-title":"Proc Natl Acad Sci USA"},{"key":"9510_CR24","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1073\/pnas.87.5.1932","volume":"87","author":"M Herkenham","year":"1990","unstructured":"Herkenham M, Lynn AB, Little MD, Johnson MR, Melvin LS, de Costa BR, Rice KC (1990) Cannabinoid receptor localization in brain. Proc Natl Acad Sci USA 87:1932\u20131936","journal-title":"Proc Natl Acad Sci USA"},{"issue":"9","key":"9510_CR25","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1016\/j.pain.2012.04.020","volume":"153","author":"JP Huggins","year":"2012","unstructured":"Huggins JP, Smart TS, Langman S, Taylor L, Young T (2012) An efficient randomised, placebo-controlled clinical trial with the irreversible fatty acid amide hydrolase-1 inhibitor PF-04457845, which modulates endocannabinoids but fails to induce effective analgesia in patients with pain due to osteoarthritis of the knee. Pain 153(9):1837\u20131846","journal-title":"Pain"},{"key":"9510_CR26","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1748-1716.1986.tb07965.x","volume":"128","author":"G Jonsson","year":"1986","unstructured":"Jonsson G, Nwanze E, Luthman J, Sundstr\u00f6m E (1986) Effect of MPTP and its pyridinium metabolites on monoamine uptake and on central catecholamine neurons in mice. Acta Physiol Scand 128:187\u2013194","journal-title":"Acta Physiol Scand"},{"key":"9510_CR27","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/nm803","volume":"9","author":"S Kathuria","year":"2003","unstructured":"Kathuria S et al (2003) Modulation of anxiety through blockade of anandamide hydrolysis. Nat Med 9:76\u201381","journal-title":"Nat Med"},{"key":"9510_CR28","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1126\/science.124.3225.723","volume":"124","author":"DL Keller","year":"1956","unstructured":"Keller DL, Umbreit W (1956) Permanent alteration of behavior in mice by chemical and psychological means. Science 124:723","journal-title":"Science"},{"key":"9510_CR29","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1111\/j.1463-1326.2009.01188.x","volume":"12","author":"MS Kipnes","year":"2010","unstructured":"Kipnes MS, Hollander P, Fujioka K, Gantz I, Seck T, Erondu N, Shentu Y, Lu K, Suryawanshi S, Chou M, Johnson-Levonas AO, Heymsfield SB, Shapiro D, Kaufman KD, Amatruda JM (2010) A one-year study to assess the safety and efficacy of the CB1R inverse agonist taranabant in overweight and obese patients with type 2 diabetes. Diabetes Obes Metab 12:517\u2013531","journal-title":"Diabetes Obes Metab"},{"key":"9510_CR30","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1111\/j.1365-2125.2011.04137.x","volume":"73","author":"GL Li","year":"2012","unstructured":"Li GL, Winter H, Arends R, Jay GW, Le V, Young T, Huggins JP (2012) Assessment of the pharmacology and tolerability of PF-04457845, an irreversible inhibitor of fatty acid amide hydrolase-1, in healthy subjects. Br J Clin Pharmacol 73:706\u2013716","journal-title":"Br J Clin Pharmacol"},{"key":"9510_CR31","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.pain.2004.01.022","volume":"109","author":"AH Lichtman","year":"2004","unstructured":"Lichtman AH, Shelton CC, Advani T, Cravatt BF (2004) Mice lacking fatty acid amide hydrolase exhibit a cannabinoid receptor-mediated phenotypic hypoalgesia. Pain 109:319\u2013327","journal-title":"Pain"},{"key":"9510_CR32","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0166-4328(89)80121-4","volume":"33","author":"J Luthman","year":"1989","unstructured":"Luthman J, Fredriksson A, Sundstr\u00f6m E, Jonsson G, Archer T (1989) Selective lesion of central dopamine or noradrenaline neuron systems in the neonatal rat: motor behavior and monoamine alterations at adult stage. Behav Brain Res 33:267\u2013277","journal-title":"Behav Brain Res"},{"key":"9510_CR33","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1177\/026988119100500437","volume":"5","author":"J Luthman","year":"1991","unstructured":"Luthman J, Fredriksson A, Plaznik A, Archer T (1991) Ketanserin and mianserin treatment reverses hyperactivity in neonatally dopamine-lesioned rats J. Psychopharmacology 5:418\u2013425","journal-title":"Psychopharmacology"},{"key":"9510_CR34","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1016\/j.lfs.2005.05.011","volume":"77","author":"K Mackie","year":"2005","unstructured":"Mackie K (2005) Cannabinoid receptor homo- and heterodimerization. Life Sci 77:1667\u20131673","journal-title":"Life Sci"},{"key":"9510_CR35","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1016\/j.neubiorev.2010.12.014","volume":"35","author":"S Macr\u00ec","year":"2011","unstructured":"Macr\u00ec S, Zoratto F, Laviola G (2011) Early-stress regulates resilience, vulnerability and experimental validity in laboratory rodents through mother-offspring hormonal transfer. Neurosci Biobehav Rev 35:1534\u20131543","journal-title":"Neurosci Biobehav Rev"},{"key":"9510_CR36","doi-asserted-by":"crossref","first-page":"e41821","DOI":"10.1371\/journal.pone.0041821","volume":"7","author":"S Macr\u00ec","year":"2012","unstructured":"Macr\u00ec S, Ceci C, Canese R, Laviola G (2012) Prenatal stress and peripubertal stimulation of the endocannabinoid system differentially regulate emotional responses and brain metabolism in mice. PloS One 7:e41821","journal-title":"PloS One"},{"key":"9510_CR37","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.neubiorev.2013.02.018","volume":"37","author":"D Martino","year":"2013","unstructured":"Martino D, Laviola G (2013) The multifaceted nature of Tourette syndrome: pre-clinical, clinical and therapeutic issues. Neurosci Biobehav Rev 37:993\u2013996","journal-title":"Neurosci Biobehav Rev"},{"key":"9510_CR38","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/B978-0-12-411546-0.00010-X","volume":"112","author":"S Mogwitz","year":"2013","unstructured":"Mogwitz S, Buse J, Ehrlich S, Roessner V (2013) Clinical pharmacology of dopamine-modulating agents in Tourette\u2019s syndrome. Int Rev Neurobiol 112:281\u2013349","journal-title":"Int Rev Neurobiol"},{"key":"9510_CR39","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.beem.2008.09.003","volume":"23","author":"FA Moreira","year":"2009","unstructured":"Moreira FA, Grieb M, Lutz B (2009) Central side-effects of therapies based on CB1 cannabinoid receptor agonists and antagonists: focus on anxiety and depression. Best Pract Res Clin Endocrinol Metab 23:133\u2013144","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"9510_CR40","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1155\/2013\/294264","volume":"27","author":"KR Muller-Vahl","year":"2013","unstructured":"Muller-Vahl KR (2013) Treatment of Tourette syndrome with cannabinoids. Behav Neurol 27:119\u2013124","journal-title":"Behav Neurol"},{"key":"9510_CR41","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1055\/s-2002-25028","volume":"35","author":"KR Muller-Vahl","year":"2002","unstructured":"Muller-Vahl KR, Schneider U, Koblenz A, Jobges M, Kolbe H, Daldrup T, Emrich HM (2002) Treatment of Tourette\u2019s syndrome with delta 9-tetrahydrocannabinol (THC): a randomized crossover trial. Pharmacopsychiatry 35:57\u201361","journal-title":"Pharmacopsychiatry"},{"key":"9510_CR42","doi-asserted-by":"crossref","first-page":"459","DOI":"10.4088\/JCP.v64n0417","volume":"64","author":"KR Muller-Vahl","year":"2003","unstructured":"Muller-Vahl KR, Schneider U, Prevedel H, Theloe K, Kolbe H, Daldrup T, Emrich HM (2003) Delta 9-tetrahydrocannabinol (THC) is effective in the treatment of tics in Tourette syndrome: a 6-week randomized trial. J Clin Psychiatry 64:459\u2013465","journal-title":"J Clin Psychiatry"},{"key":"9510_CR43","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1098\/rspb.2000.1057","volume":"267","author":"CM Nevison","year":"2000","unstructured":"Nevison CM, Barnard CJ, Beynon RJ, Hurst JL (2000) The consequences of inbreeding for recognizing competitors. Proc R Soc Lond Ser B 267:687\u2013694","journal-title":"Proc R Soc Lond Ser B"},{"key":"9510_CR44","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0006-8993(99)01137-3","volume":"835","author":"MP Paulus","year":"1999","unstructured":"Paulus MP, Dulawa SC, Ralph RJ, Mark AG (1999) Behavioral organization is independent of locomotor activity in 129 and C57 mouse strains. Brain Res 835:27\u201336","journal-title":"Brain Res"},{"key":"9510_CR45","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1527-3458.2006.00021.x","volume":"12","author":"D Piomelli","year":"2006","unstructured":"Piomelli D, Tarzia G, Duranti A, Tontini A, Mor M, Compton TR, Dasse O, Monaghan EP, Parrott JA, Putman D (2006) Pharmacological profile of the selective FAAH inhibitor KDS-4103 (URB597). CNS Drug Rev 12:21\u201338","journal-title":"CNS Drug Rev"},{"key":"9510_CR46","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.bbr.2014.03.023","volume":"267","author":"M Proietti Onori","year":"2014","unstructured":"Proietti Onori M, Ceci C, Laviola G, Macr\u00ec S (2014) A behavioural test battery to investigate tic-like symptoms, stereotypies, attentional capabilities, and spontaneous locomotion in different mouse strains. Behav Brain Res 267:95\u2013105","journal-title":"Behav Brain Res"},{"key":"9510_CR47","first-page":"107","volume":"36","author":"L Rinaldi","year":"1994","unstructured":"Rinaldi L (1994) Marijuana: a research overview. Alsk Med 36:107\u2013113","journal-title":"Alsk Med"},{"key":"9510_CR48","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1097\/00004714-198812000-00021","volume":"8","author":"R Sandyk","year":"1988","unstructured":"Sandyk R, Awerbuch G (1988) Marijuana and Tourette\u2019s syndrome. J Clin Psychopharmacol 8:444\u2013445","journal-title":"J Clin Psychopharmacol"},{"key":"9510_CR49","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1124\/jpet.108.142224","volume":"327","author":"M Scherma","year":"2008","unstructured":"Scherma M, Panlilio LV, Fadda P, Fattore L, Gamaleddin I, Le Foll B, Justinov\u00e1 Z, Mikics E, Haller J, Medalie J, Stroik J, Barnes C, Yasar S, Tanda G, Piomelli D, Fratta W, Goldberg SR (2008) Inhibition of anandamide hydrolysis by cyclohexyl carbamic acid 3\u2032-carbamoyl-3-yl ester (URB597) reverses abuse-related behavioral and neurochemical effects of nicotine in rats. J Pharmacol Exp Ther 327:482\u2013490","journal-title":"J Pharmacol Exp Ther"},{"key":"9510_CR50","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.pnpbp.2005.11.008","volume":"30","author":"L Schiller","year":"2006","unstructured":"Schiller L, Donix M, Jahkel M, Oehler J (2006) Serotonin 1A and 2A receptor densities, neurochemical and behavioural characteristics in two closely related mice strains after long-term isolation. Prog Neuropsychopharmacol Biol Psychiatry 30:492\u2013503","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"9510_CR51","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/j.1471-4159.2006.03880.x","volume":"98","author":"M Solinas","year":"2006","unstructured":"Solinas M, Justinova Z, Goldberg SR, Tanda G (2006) Anandamide administration alone and after inhibition of fatty acid amide hydrolase (FAAH) increases dopamine levels in the nucleus accumbens shell in rats. J Neurochem 98:408\u2013419","journal-title":"J Neurochem"},{"key":"9510_CR52","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1901\/jaba.2001.34-353","volume":"34","author":"DW Woods","year":"2001","unstructured":"Woods DW, Watson TS, Wolfe E, Twohig MP, Friman PC (2001) Analyzing the influence of tic-related talk on vocal and motor tics in children with Tourette\u2019s syndrome. J Appl Behav Anal 34:353\u2013356","journal-title":"J Appl Behav Anal"},{"key":"9510_CR53","first-page":"469","volume":"9","author":"Y Yao","year":"2007","unstructured":"Yao Y, Ma HW, Lu Y, Dai XM (2007) Roles of fluoxetine and haloperidol in mouse models of DOI-induced head twitch response. Zhongguo Dang Dai Er Ke Za Zhi 9:469\u2013472","journal-title":"Zhongguo Dang Dai Er Ke Za Zhi"},{"key":"9510_CR54","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1097\/FBP.0b013e3283566065","volume":"23","author":"SA Zaitone","year":"2012","unstructured":"Zaitone SA, El-Wakeil AF, Abou-El-Ela SH (2012) Inhibition of fatty acid amide hydrolase by URB597 attenuates the anxiolytic-like effect of acetaminophen in the mouse elevated plus-maze test. Behav Pharmacol 23:417\u2013425","journal-title":"Behav Pharmacol"},{"key":"9510_CR55","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0304-3940(99)00762-4","volume":"276","author":"BY Zeng","year":"1999","unstructured":"Zeng BY, Dass B, Owen A, Rose S, Cannizzaro C, Tel BC, Jenner P (1999) Chronic L-DOPA treatment increases striatal cannabinoid CB1 receptor mRNA expression in 6-hydroxydopamine-lesioned rats. Neurosci Lett 276:71\u201374","journal-title":"Neurosci Lett"},{"key":"9510_CR56","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.neuropharm.2006.11.009","volume":"52","author":"D Zhang","year":"2007","unstructured":"Zhang D, Saraf A, Kolasa T, Bhatia P, Zheng GZ, Patel M, Lannoye GS, Richardson P, Stewart A, Rogers JC, Brioni JD, Surowy CS (2007) Fatty acid amide hydrolase inhibitors display broad selectivity and inhibit multiple carboxylesterases as off-targets. Neuropharmacology 52:1095\u20131105","journal-title":"Neuropharmacology"}],"container-title":["Neurotoxicity Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12640-014-9510-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12640-014-9510-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12640-014-9510-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T13:31:28Z","timestamp":1559482288000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12640-014-9510-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12,17]]},"references-count":57,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["9510"],"URL":"https:\/\/doi.org\/10.1007\/s12640-014-9510-z","relation":{},"ISSN":["1029-8428","1476-3524"],"issn-type":[{"value":"1029-8428","type":"print"},{"value":"1476-3524","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12,17]]}}}